Get the Stockscreener App
10.36
0.98%
0.105
Certara Inc stock is traded at $10.36, with a volume of 382.11K.
It is up +0.98% in the last 24 hours and down -6.67% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$10.25
Open:
$10.12
24h Volume:
382.11K
Relative Volume:
0.31
Market Cap:
$1.67B
Revenue:
$360.69M
Net Income/Loss:
$-61.40M
P/E Ratio:
86.29
EPS:
0.12
Net Cash Flow:
$60.93M
1W Performance:
+0.00%
1M Performance:
-6.67%
6M Performance:
-41.19%
1Y Performance:
-19.20%
1-Day Range:
$10.07
$10.39
1-Week Range:
$10.05
$10.60
52-Week Range:
$9.99
$19.87
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Robert W. Baird Issues Pessimistic Forecast for Certara (NASDAQ:CERT) Stock Price - MarketBeat
Certara stock target cut, maintains neutral rating amid spending concerns - Investing.com India
Certara price target lowered to $13 from $18 at Baird - TipRanks
Drug Discovery Informatics Market Size Set to Surpass USD - GlobeNewswire
Biosimulation Market Segments, Drivers, Restraints, And Trends For 2024-2033 - EIN News
Biosimulation Market is expected to Double Its Size by Upcoming - openPR
Certara (CERT) to Release Quarterly Earnings on Wednesday - MarketBeat
Certara to Participate in the Stephens Annual Investment Conference - ForexTV.com
Certara, Inc. (NASDAQ:CERT) Shares Could Be 23% Above Their Intrinsic Value Estimate - Yahoo Finance
How To Trade (CERT) - Stock Traders Daily
Certara (NASDAQ:CERT) Hits New 12-Month LowHere's Why - MarketBeat
Certara stock hits 52-week low at $10.35 amid market challenges - Investing.com
Is Certara, Inc. (NASDAQ:CERT) Potentially Undervalued? - Simply Wall St
Certara (NASDAQ:CERT) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Certara adds pharmaceutical veteran to board - Investing.com India
Analysts Set Certara, Inc. (NASDAQ:CERT) Target Price at $17.08 - MarketBeat
Globe Life Inc. (NYSE:GL) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Certara appoints new director to its board By Investing.com - Investing.com Australia
Certara Appoints John Reynders as Board Member - citybiz
Certara appoints new director to its board - Investing.com India
Certara Appoints John Reynders as New Independent Board Member - The Manila Times
Certara adds pharmaceutical veteran to board By Investing.com - Investing.com UK
380,638 Shares in Certara, Inc. (NASDAQ:CERT) Bought by Kopion Asset Management LLC - MarketBeat
Barclays Lowers Certara (NASDAQ:CERT) Price Target to $14.00 - MarketBeat
Beyond The Numbers: 4 Analysts Discuss Certara Stock - Benzinga
Trading Day Review: Certara Inc (CERT) Loses Momentum, Closing at 11.24 - The Dwinnex
Certara price target lowered to $14 from $16 at Barclays - TipRanks
Certara Inc (CERT) is looking forward to a strong quarter - SETE News
In Silico Clinical Trials Market 2024-2031- Certara, Inc., Novadiscovery Sas, Insilico Medicine, Inc., Dassault Systemes - IndiaPolitics.com
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024 - ForexTV.com
Taking a Closer Look At Certara Inc (CERT) Following Its Recent Trade - Knox Daily
A stock that deserves closer examination: Certara Inc (CERT) - US Post News
Certara executive sells $59,661 in company stock By Investing.com - Investing.com Canada
Insider Sale at Certara Inc (CERT): President of Drug Developmen - GuruFocus.com
Certara executive sells $59,661 in company stock - Investing.com India
Patrick F. Smith Sells 5,409 Shares of Certara, Inc. (NASDAQ:CERT) Stock - MarketBeat
Financial Health Report: Certara Inc (CERT)’s Ratios Tell a Tale - The Dwinnex
This trade activity should not be overlooked: Certara Inc (CERT) - SETE News
Thrivent Financial for Lutherans Reduces Position in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Market Watch: Certara Inc (CERT)’s Noteworthy Gain, Closing at 11.37 - The Dwinnex
Clearbridge Investments LLC Has $56.61 Million Holdings in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Certara Completes Chemaxon Acquisition - citybiz
Certara acquires Chemaxon to enhance drug development - Investing.com India
Certara Completes Acquisition of Chemaxon - ForexTV.com
Certara acquires Chemaxon to enhance drug development By Investing.com - Investing.com UK
Monitoring Certara Inc (CERT) after recent insider movements - Knox Daily
Certara Inc (CERT) is a good investment, but the stock may be undervalued - US Post News
A new trading data show Certara Inc (CERT) is showing positive returns. - SETE News
Dimensional Fund Advisors LP Purchases 273,095 Shares of Certara, Inc. (NASDAQ:CERT) - MarketBeat
Certara Inc (CERT) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
High Growth Tech Stocks To Watch In September 2024 - Simply Wall St
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):